Ortho-Clinical Diagnostics, Inc. VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood. Product Code: 6842905 Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood. Product Code: 6842905
Brand
Ortho-Clinical Diagnostics, Inc.
Lot Codes / Batch Numbers
UDI-DI: 10758750030729 Lot Number/Expiry: 29-9396 2023-SEP-02, 29-9466 2023-SEP-02, 30-9647 2023-NOV-25, 30-9803 2023-NOV-25, 31-9648 2024-JAN-24, 32-9925 2024-APR-14, 33-1097 2024-JUL-18, 33-1105 2024-JUL-18, 33-1228 2024-JUL-18
Products Sold
UDI-DI: 10758750030729 Lot Number/Expiry: 29-9396 2023-SEP-02; 29-9466 2023-SEP-02; 30-9647 2023-NOV-25; 30-9803 2023-NOV-25; 31-9648 2024-JAN-24; 32-9925 2024-APR-14; 33-1097 2024-JUL-18; 33-1105 2024-JUL-18; 33-1228 2024-JUL-18; 34-1345* 2024-OCT-17. All lots within expiry (listed above) as well as future lots until your laboratory receives an additional notification from Ortho
Ortho-Clinical Diagnostics, Inc. is recalling VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glyca due to Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis
Recommended Action
Per FDA guidance
Ortho Clinical Diagnostics (Ortho) issued to Dealers and End-Users Urgent Product Correction Notification Potential Bias Observed in VITROS Chemistry Products HbA1c Reagent Kit on 4/17/23. Letter states reason for recall, health risk and action to take: In an abundance of caution, the required actions are applicable to all lots within expiry ( as well as future lots until your laboratory receives an additional notification from Ortho. However, while data is limited, a review of the release testing indicated no other lots were impacted. Reagent Pack Used for Calibration o If your system currently has multiple HbA1c reagent packs, leave one reagent pack on the system and unload all other reagent packs and store at 2-8 oC (36-46 oF) until needed. o Calibrate the one HbA1c reagent pack on your system. o Perform QC after successful calibration. QC must be acceptable and subsequently performed every 8 hours of testing, for the first 2 days that the reagent pack is onboard the system. o If QC fails with a negative bias, troubleshoot according to your laboratory s procedure. o If QC fails with a positive bias, load a new pack and re-calibrate following the required actions. Review the patient results since the last passing QC by your Medical Director. o After 2 days of passing within your laboratory s established QC range, performing QC every 8 hours is no longer necessary on that pack. Refer to Testing section below for QC requirements after calibration. Reagent Pack Loading Only have one reagent pack loaded onboard your VITROS System at a time. " Reagent Pack Used for Testing o Once the reagent pack used for calibration is depleted, QC must be performed upon loading each reagent pack and must be within the laboratory s established QC range prior to patient testing. o If the QC results are outside your laboratory s established range with a negative bias, then discard that reagent pack and load a new pack to perform QC again. o Ortho s observed data does not demonstrate
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026